scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding scPharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 63 | 81 | +18 |
| Shares | 24.6M | 28.5M | +3.94M (+16.0%) |
| Value | $223.2M | $290.8M | +$67.6M (+30.3%) |
New holders (33)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (15)
Institutions that held scPharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Goldman Sachs Group Inc | 109,132 | $989.8K |
| Cubist Systematic Strategies, LLC | 91,453 | $829.5K |
| ClariVest Asset Management LLC | 80,784 | $733.0K |
| Squarepoint Ops LLC | 74,205 | $673.0K |
| HRT Financial LP | 65,198 | $591.0K |
| Marshall Wace, LLP | 52,380 | $475.1K |
| Zacks Investment Management | 32,416 | $294.0K |
| Qube Research & Technologies Ltd | 31,416 | $284.9K |
| CM Wealth Advisors LLC | 21,357 | $203.0K |
| 683 Capital Management, LLC | 21,000 | $190.5K |
| Man Group plc | – | $123.4K |
| LMR Partners LLP | 12,726 | $115.4K |
| Verition Fund Management LLC | 12,358 | $112.1K |
| Point72 Middle East FZE | 3,727 | $33.8K |
| Point72 Asset Management, L.P. | 500 | $4.54K |